-
Something wrong with this record ?
Malonate-based inhibitors of mammalian serine racemase: kinetic characterization and structure-based computational study
B. Vorlová, D. Nachtigallová, J. Jirásková-Vaníčková, H. Ajani, P. Jansa, J. Rezáč, J. Fanfrlík, M. Otyepka, P. Hobza, J. Konvalinka, M. Lepšík,
Language English Country France
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Enzyme Inhibitors chemical synthesis chemistry pharmacology MeSH
- Kinetics MeSH
- Crystallography, X-Ray MeSH
- Malonates chemical synthesis chemistry pharmacology MeSH
- Models, Molecular MeSH
- Molecular Structure MeSH
- Mice MeSH
- Racemases and Epimerases antagonists & inhibitors metabolism MeSH
- Thermodynamics MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Overactivation of NMDA receptors has been implicated in various neuropathological conditions, including brain ischaemia, neurodegenerative disorders and epilepsy. Production of d-serine, an NMDA receptor co-agonist, from l-serine is catalyzed in vivo by the pyridoxal-5'-phosphate (PLP)-dependent enzyme serine racemase. Specific inhibition of this enzyme has been proposed as a promising strategy for treatment of neurological conditions caused by NMDA receptor dysfunction. Here we present the synthesis and activity analysis of a series of malonate-based inhibitors of mouse serine racemase (mSR). The compounds possessed IC50 values ranging from 40 ± 11 mM for 2,2-bis(hydroxymethyl)malonate down to 57 ± 1 μM for 2,2-dichloromalonate, the most effective competitive mSR inhibitor known to date. The structure-activity relationship of the whole series in the human orthologue (hSR) was interpreted using Glide docking, WaterMap analysis of hydration and quantum mechanical calculations based on the X-ray structure of the hSR/malonate complex. Docking into the hSR active site with three thermodynamically favourable water molecules was able to discern qualitatively between good and weak inhibitors. Further improvement in ranking was obtained using advanced PM6-D3H4X/COSMO semiempirical quantum mechanics-based scoring which distinguished between the compounds with IC50 better/worse than 2 mM. We have thus not only found a new potent hSR inhibitor but also worked out a computer-assisted protocol to rationalize the binding affinity which will thus aid in search for more effective SR inhibitors. Novel, potent hSR inhibitors may represent interesting research tools as well as drug candidates for treatment of diseases associated with NMDA receptor overactivation.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000492
- 003
- CZ-PrNML
- 005
- 20160125110145.0
- 007
- ta
- 008
- 160108s2015 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejmech.2014.10.043 $2 doi
- 035 __
- $a (PubMed)25462239
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Vorlová, Barbora $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic; Department of Biochemistry, Faculty of Natural Science, Charles University, Albertov 6, 128 43 Prague 2, Czech Republic.
- 245 10
- $a Malonate-based inhibitors of mammalian serine racemase: kinetic characterization and structure-based computational study / $c B. Vorlová, D. Nachtigallová, J. Jirásková-Vaníčková, H. Ajani, P. Jansa, J. Rezáč, J. Fanfrlík, M. Otyepka, P. Hobza, J. Konvalinka, M. Lepšík,
- 520 9_
- $a Overactivation of NMDA receptors has been implicated in various neuropathological conditions, including brain ischaemia, neurodegenerative disorders and epilepsy. Production of d-serine, an NMDA receptor co-agonist, from l-serine is catalyzed in vivo by the pyridoxal-5'-phosphate (PLP)-dependent enzyme serine racemase. Specific inhibition of this enzyme has been proposed as a promising strategy for treatment of neurological conditions caused by NMDA receptor dysfunction. Here we present the synthesis and activity analysis of a series of malonate-based inhibitors of mouse serine racemase (mSR). The compounds possessed IC50 values ranging from 40 ± 11 mM for 2,2-bis(hydroxymethyl)malonate down to 57 ± 1 μM for 2,2-dichloromalonate, the most effective competitive mSR inhibitor known to date. The structure-activity relationship of the whole series in the human orthologue (hSR) was interpreted using Glide docking, WaterMap analysis of hydration and quantum mechanical calculations based on the X-ray structure of the hSR/malonate complex. Docking into the hSR active site with three thermodynamically favourable water molecules was able to discern qualitatively between good and weak inhibitors. Further improvement in ranking was obtained using advanced PM6-D3H4X/COSMO semiempirical quantum mechanics-based scoring which distinguished between the compounds with IC50 better/worse than 2 mM. We have thus not only found a new potent hSR inhibitor but also worked out a computer-assisted protocol to rationalize the binding affinity which will thus aid in search for more effective SR inhibitors. Novel, potent hSR inhibitors may represent interesting research tools as well as drug candidates for treatment of diseases associated with NMDA receptor overactivation.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a inhibitory enzymů $x chemická syntéza $x chemie $x farmakologie $7 D004791
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a malonáty $x chemická syntéza $x chemie $x farmakologie $7 D008314
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a racemasy a epimerasy $x antagonisté a inhibitory $x metabolismus $7 D019998
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a termodynamika $7 D013816
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nachtigallová, Dana $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Jirásková-Vaníčková, Jana $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic; Department of Biochemistry, Faculty of Natural Science, Charles University, Albertov 6, 128 43 Prague 2, Czech Republic.
- 700 1_
- $a Ajani, Haresh $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic; Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Palacky University, 771 46 Olomouc, Czech Republic. $7 gn_A_00002766
- 700 1_
- $a Jansa, Petr $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Rezáč, Jan $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Fanfrlík, Jindřich $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Otyepka, Michal $u Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Palacky University, 771 46 Olomouc, Czech Republic.
- 700 1_
- $a Hobza, Pavel $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic; Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Palacky University, 771 46 Olomouc, Czech Republic.
- 700 1_
- $a Konvalinka, Jan $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic; Department of Biochemistry, Faculty of Natural Science, Charles University, Albertov 6, 128 43 Prague 2, Czech Republic. Electronic address: konval@uochb.cas.cz.
- 700 1_
- $a Lepšík, Martin $u Institute of Organic Chemistry and Biochemistry, Gilead Sciences and IOCB Research Centre, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic. Electronic address: lepsik@uochb.cas.cz.
- 773 0_
- $w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 89, č. - (2015), s. 189-97
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25462239 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20160125110308 $b ABA008
- 999 __
- $a ok $b bmc $g 1102773 $s 924698
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 89 $c - $d 189-97 $e 20141016 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
- LZP __
- $a Pubmed-20160108